Newsroom press releases

31/07/25 - 16:22

Revenue Growth and Margin Expansion in H1 2025. FY 2025 Guidance Confirmed (238.17 KB)

Financial Data

02/07/25 - 8:10

Diasorin submits the LIAISON NES® Point-of-Care molecular diagnostics system and 4-plex Respiratory Panel to the FDA for 510(k) Clearance and CLIA Waiver (133.82 KB)

Products Molecular

07/06/25 - 12:25

Diasorin announces 510(k) clearance for LIAISON PLEX® Gram-Positive Blood Culture Assay, to complete the Blood Culture portfolio on LIAISON PLEX® (143.05 KB)

Products Molecular

06/05/25 - 17:41

Revenue growing +8% and EBITDA margin at 34%: Q1 Results confirm FY 2025 Guidance (268.56 KB)

Financial Data

18/04/25 - 18:11

Diasorin receives 510(k) clearance for its second multiplex molecular panel for diagnosing bloodstream infections on LIAISON PLEX® (161.29 KB)

Products

18/03/25 - 11:54

Diasorin launches the Simplexa™ C. auris direct assay on the LIAISON® MDX instrument in all countries accepting the CE Mark (126.65 KB)

Products Molecular

14/03/25 - 16:29

The Board of Directors of Diasorin SpA approves FY2024 Results with revenues and net profit in expansion compared to Previous Year; Proposed Ordinary Dividend of € 1.20 per share (239.79 KB)

Financial Data

11/11/15 - 1:00

The Board of Directors approves the results for Q3'15 (778.06 KB)

Financial Data

09/09/15 - 2:00

DiaSorin launches the two fastest molecular diagnostic tests in the world to detect fulminant leukemias (229.24 KB)

Products Molecular

30/07/15 - 2:00

H1'15 Results (777.06 KB)

Financial Data

20/07/15 - 2:00

DiaSorin and Beckman Coulter sign a distribution agreement for China (238.01 KB)

Acquisition / Partnership

28/05/15 - 2:00

DiaSorin launches the test for Campylobacter (241.86 KB)

Products Immunodiagnostic

12/05/15 - 2:00

DiaSorin presents the 2015-2017 industrial plan (305.81 KB)

Other

12/05/15 - 2:00

The Board of Directors approves the results for Q1'15 (553.96 KB)

Financial Data

29/04/15 - 2:00

DiaSorin - launches the test for Brahms-Sepsis (506.96 KB)

Products Immunodiagnostic

23/04/15 - 2:00

DiaSorin supports the Pinocchio Project (251.16 KB)

22/04/15 - 2:00

The Board of Directors approves the 2015-2017 plan that will be presented at the Investor Day (141.85 KB)

Financial Data

22/04/15 - 2:00

Shareholders' meeting approves FY Results 2014 (105.93 KB)

Financial Data

14/04/15 - 2:00

DiaSorin launches the tests for Bordetella pertussis (187.11 KB)

Products Immunodiagnostic

10/04/15 - 2:00

Investor Day-save the date (107.93 KB)

Financial Data

24/03/15 - 1:00

DiaSorin in aid of Haiti's children in partnership with the Francesca Rava Foundation (504.27 KB)

03/03/15 - 1:00

The Board of Directors approves the results for FY'14 (783.03 KB)

Financial Data

24/02/15 - 1:00

DiaSorin supports Emergency in Sudan (612.64 KB)

13/02/15 - 1:00

DiaSorin teams with FISIP for Progetto talenti (612.64 KB)

14/01/15 - 1:00

DiaSorin launches the test for Calprotectin (259.67 KB)

Products Immunodiagnostic